
Seme Burka, MD🫀
484 posts

Seme Burka, MD🫀
@SBurkaMD
FIT preventive cardiology @ciccaronecenter @Hopkinsheart//geriatrician @pittgerimed//IM @UTRGV//Winn CDA scholar @winnawards//2024 lipid scholar @nationallipid




From 2019 to 2024, US #Nonstatin lipid-lowering therapy prescriptions doubled but remain a smaller proportion than #Statin use, with cardiologists prescribing nonstatins more intensively than primary care clinicians. ja.ma/4vBFN5E




Congratulations to @CiccaroneCenter Preventive Cardiology Fellows Seme Burka & Yara Jelwan on their great 2 year fellowship at @HopkinsHeart & their principal mentor @Michaeljblaha. Best of luck on your next adventures in New Orleans & Cleveland! #🥍🐦🫀🏏🏊🏼♀️⛳️🏌️♀️🏀






Dr. Keith Ferdinand’s extraordinary impact on heart health begins at home, in New Orleans’ Ninth Ward, and extends nationwide. Through clinical excellence, community-based care, and visionary leadership in hypertension, he is helping close gaps in cardiovascular outcomes and expand access to better health for all. Please join me in celebrating @kcferdmd, the American Heart Association’s 2026 Physician of the Year. Read his story: heart.org/en/around-the-…











US Trends in Prescribing Nonstatin Lipid-Lowering Therapy, 2019-2024 jamanetwork.com/journals/jamac…







In pulmonary hypertension (PH), chronic pressure overload can progress from adaptive right ventricular (RV) hypertrophy to maladaptive remodeling, characterized by RV dilation, fibrosis, stiffness, and RV–pulmonary artery uncoupling. This statement summarizes current knowledge on RV dysfunction in PH, emphasizing its mechanisms, clinical relevance, and therapeutic potential. ✍🏼 @PullamsettiL @sbonnet2 @RRVdpool @Viniciodjperez



